News from diplomat pharmacy A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 22, 2015, 16:01 ET
Diplomat Specialty Pharmacy

Diplomat to Release First Quarter Operating Results and Host Conference Call on Monday, May 11, 2015

 Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, will release its first quarter operating results on...

Apr 17, 2015, 16:30 ET
Diplomat Specialty Pharmacy

Diplomat Launches National Search for Internship and Fellowship in Flint

Diplomat Pharmacy, Inc. (NYSE: DPLO) announced that it is seeking applicants for their annual Internship and Fellowship programs for the summer of...

Apr 16, 2015, 16:30 ET
Diplomat Specialty Pharmacy

Diplomat Names Shannon M. Beltrand as New CISO

 Diplomat Pharmacy, Inc. (NYSE: DPLO) announced the addition of Shannon Beltrand to their senior leadership team as chief information security...

Apr 13, 2015, 16:48 ET
Diplomat Specialty Pharmacy

Diplomat to Dispense Novartis Drug, JADENU™

Diplomat Pharmacy, Inc. (NYSE: DPLO) to distribute JADENU™, a drug recently approved by the U.S. Food and Drug Administration to treat...

Apr 03, 2015, 08:58 ET
Diplomat Specialty Pharmacy

Diplomat Celebrates 40th Anniversary

Diplomat Pharmacy, Inc. (NYSE: DPLO) is celebrating 40 years of providing quality pharmacy services to its patients nationwide. Diplomat, founded...

Apr 01, 2015, 17:06 ET
Diplomat Specialty Pharmacy

Diplomat Completes Acquisition of BioRx

 Diplomat Pharmacy, Inc. (NYSE: DPLO), announced today it has completed the acquisition of BioRx, LLC, a highly specialized pharmacy and...

Mar 31, 2015, 14:12 ET
Diplomat Specialty Pharmacy

Diplomat announces closing of follow-on public offering and full exercise of option by underwriters

Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, announced today the closing of its follow-on public...

Mar 25, 2015, 21:00 ET
Diplomat Specialty Pharmacy

Diplomat announces pricing of follow-on public offering of common stock

Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, announced today the pricing of its follow-on public...

Mar 23, 2015, 16:05 ET
Diplomat Specialty Pharmacy

Diplomat announces launch of public offering of common stock

 Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, announced today that it has commenced its follow-on...

Mar 17, 2015, 08:45 ET
Diplomat Specialty Pharmacy

Diplomat Selected to Dispense KITABIS™ PAK for Cystic Fibrosis

 Diplomat Pharmacy, Inc. (NYSE: DPLO) announced its selection today to the limited-distribution panel for PARI's KITABIS™ PAK, recently...

Mar 13, 2015, 17:16 ET
Diplomat Specialty Pharmacy

Diplomat announces filing of registration statement for a proposed public offering of common stock

 Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, announced today the filing of a registration...

Mar 04, 2015, 07:50 ET
Diplomat Specialty Pharmacy

Diplomat to Dispense Novartis Psoriasis Drug COSENTYX™

 Diplomat Pharmacy, Inc. (NYSE: DPLO) has been selected to the Novartis limited-distribution panel  to distribute COSENTYX™...

Mar 02, 2015, 16:10 ET
Diplomat Specialty Pharmacy

Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance

  Click here for additional information on the earnings results. Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent...

Feb 26, 2015, 08:00 ET
Diplomat Specialty Pharmacy

Diplomat to expand infusion services with acquisition of BioRx

 Click here for additional information regarding the transaction. Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent...

Feb 25, 2015, 08:00 ET
Diplomat Specialty Pharmacy

Diplomat to Dispense Novartis Myeloma Drug FARYDAK®

Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that the U.S. Food and Drug Administration has approved FARYDAK® (panobinostat) for the...

Feb 20, 2015, 13:19 ET
Diplomat Specialty Pharmacy

Diplomat Pharmacy, Inc. Announces 2015 Annual Meeting Date

 Diplomat Pharmacy, Inc. (the "Company") (NYSE: DPLO) today announced that it has set June 5, 2015 as the date for the Company's 2015 Annual...

Feb 19, 2015, 09:27 ET
Diplomat Specialty Pharmacy

Diplomat to Release Fourth Quarter and Year End Operating Results and Host Conference Call on Monday, March 2, 2015

 Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, will release its fourth quarter and year end 2014...

Feb 04, 2015, 17:05 ET
Diplomat Specialty Pharmacy

IBRANCE® (palbociclib) approved for advanced breast cancer, Diplomat to dispense

 Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, announced today it will dispense Pfizer's new...

Feb 02, 2015, 16:56 ET
Diplomat Specialty Pharmacy

Diplomat earns Verified Internet Pharmacy Practice Sites® (VIPPS®) accreditation

 Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, announced today that it has earned the Verified...

Jan 29, 2015, 17:24 ET
Diplomat Specialty Pharmacy

IMBRUVICA® (ibrutinib) receives expanded approval for treatment of Waldenstrom's macroglobulinemia

 Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, announced today that the U.S. Food and Drug...